New Hampshire

New Hampshire

State Facts

245

Deaths or 87.2% of total overdose deaths involved opioids in 2024.¹

216,462

Claims or 3.41% of all Medicare Part D claims were for opioids in 2022 – an average of 31 per prescriber.²

30.9

Opioid Prescriptions were written for every 100 persons in New Hampshire in 2023.³

5,476

Beneficiaries on Medicare Part D had Opioid Use Disorder in 2022.⁴

Download FactSheet

Opioid Settlement Funds

$268,566,522.08
State Spending Recommendation

Support use of non-opioid pain treatment alternatives, including training providers to offer or refer to multi-modal, evidence-informed treatment of pain

Member & Endorser Footprint

Voices is backed by a broad coalition of organizations across the state united by a shared goal: ensuring patients have access to safe, effective, 
and individualized pain management throughout the continuum of care.

Co-Sponsors (119th)

Sen. Jeanne Shaheen (D-NH)

Sen. Jeanne Shaheen (D-NH)

2025 Introduced Relevant Legislation

HB 241

This legislation mandates that insurance providers cover a variety of pain management therapies as alternatives to opioid treatments, prohibiting insurers from imposing more restrictive utilization controls on non-opioid therapies compared to those applied to opioid drugs.

Introduced
01/07/2025
Plan Impact
Commercial
Learn More

Voices Letters

HB 241 Support Letter

Learn More

1. Centers for Disease Control and Prevention (2025). Provisional Drug Overdose Death Counts. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm

2. Centers for Disease Control and Prevention (2024). Medicare Part D Opioid Prescribing Mapping Tool. https://cms-oeda.maps.arcgis.com/apps/MapSeries/index.html?appid=5390718d875d4c049b1ac5976a9ff083

3. Center for Disease Control and Prevention (2024). Opioid Dispensing Rate Maps. https://www.cdc.gov/overdose-prevention/data-research/facts-stats/opioid-dispensing-rate-maps.html

4. Office of the Inspector General (2023). The Consistently Low Percentage of Medicare Enrollees Receiving Medication to Treat Their Opioid Use Disorder Remains a Concern. https://oig.hhs.gov/documents/evaluation/2722/OEI-02-23-00250-Complete%20Report.pdf